Vaccines World Summit

Concept
Agenda
Sponsors & Exhibitors
Related Events

Sponsorship Prospectus

contact form

First Name*

Last Name*

Function*

Job Title*

Company*

Country*

Contact Number*

Email*

How did you hear about us?

Products of Interest
Blood Plasma ProductsAntibody TherapeuticsProtein TherapeuticsViral VaccinesCell TherapyGene TherapyImmunotherapeuticsMedical DeviceOther BiologicsNon-Biologics

Subscribe to our mailing list
By checking the box above, you acknowledge and agree to IMAPAC’s Terms of Service and to use your contact information provided to communicate with you about offerings by IMAPAC, its brands, affiliates and/or third-party partners consistent with IMAPAC’s Privacy Policy.

Advancing Vaccines Business, Technology and Innovation in Developing Economies

11 - 12 May, 2022
In-Person & Live Online

Download Brochure

contact form

First Name*

Last Name*

Function*

Job Title*

Company*

Country*

Contact Number*

Email*

How did you hear about us?

Products of Interest
Blood Plasma ProductsAntibody TherapeuticsProtein TherapeuticsViral VaccinesCell TherapyGene TherapyImmunotherapeuticsMedical DeviceOther BiologicsNon-Biologics

#VWS Experience Shared

It's my pleasure to be a participant in IMAPAC's 11th World Vaccine Summit. This virtual platform supported in exploring more on the current trends on vaccine developments from various manufacturers/ research centters

BravoVax

China

Excellent event with with good knowledge-sharing by experienced scientists globally to combat present situation and challenges faced by the vaccines manufacturing industry. Kind hospitality by IMAPAC...Keep it up.

Hester Biosciences Limited

India

Talks were very interesting addressing subjects really important such as the balance of Th1 and Th2 cells as immune response of COVID-19 vaccines. I watched a lot watching and rewatching the videos too.

Instituto Butantan

Brazil

Attendees Representing Vaccine Manufacturers, Institutes, Regulators

Companies From India, China, Africa, Brazil, Russia And More!

Speakers Sharing Their Expertise

In-Person Networking Hours

Case Studies

The Concept

The Vaccines World Summit 2022 is the only vaccine conference dedicated to the Asia Pacific vaccine manufacturing sector. This event connects leaders in manufacturing, R&D and supply chain from vaccine manufacturing companies to debate best practices in vaccine manufacturing in Asia, share intelligence and network.

Addressing key hurdles to achieving rapid time to market efficiently, the conference illuminates the road forward for data usage, software and innovative solutions.

This 2-day event features a 2-day conference that will be delivered in a hybrid event format, combining an in-person conference experience with a virtual component.

Download Brochure

contact form

First Name*

Last Name*

Function*

Job Title*

Company*

Country*

Contact Number*

Email*

How did you hear about us?

Products of Interest
Blood Plasma ProductsAntibody TherapeuticsProtein TherapeuticsViral VaccinesCell TherapyGene TherapyImmunotherapeuticsMedical DeviceOther BiologicsNon-Biologics

Past Program

Vaccination programs save millions of lives each year globally. With more than 100 million children immunized each year, global immunization coverage has never been higher. Sources indicate that the worldwide market for vaccines is expected to reach USD 48.03 Billion by 2021 from USD 32.24 Billion in 2016 at a CAGR of 8.3% from 2016 to 2021. The key drivers driving the growth of this market are a high prevalence of diseases, rising government and nongovernment funding for vaccine development, increasing investments by companies, and increasing focus on immunization programs. With factors such as advances in immunology, genetics, and vaccine technology as well as increased demand from population growth in emerging economies, the global vaccine market is expected to surpass an estimated USD 100 billion by 2025. The economies of developing countries, for example, India is growing at a tremendous speed, and it is expected to grow 10-15% within the next decade. Emerging manufacturers play a critical role in the supply of vaccines of developing countries, particularly basic and some combination vaccines. 30% of UNICEF’s total procurement comes from emerging manufacturers. The decrease in vaccine prices can also be attributed to increased competition and higher production capacities for individual vaccines brought about by the entry of emerging market manufacturers, particularly in the underused vaccines market. Vaccines World Summit, for developing economies, aims to bring together key experts and decision-makers from vaccine manufacturers, governmental organizations, regulators, non-profit organizations, and solution providers together to aid in advancements in this industry with significantly higher collaboration.

COVID-19 Vaccine Action Plan in Asian Countries

Effective Strategies to Produce and Manufacture COVID-19 Vaccine at Scale and Pace

Ramping Up COVID-19 Vaccine Fill & Finish Capacity

Vaccines for Emerging Viral Diseases

Clinical Trial Results from Next- Gen and New Pipelines in the Industry

New Approaches to Evaluating Vaccine Quality Control & Safety

Production and Tech Transfers to Speed Up Local Vaccine Production

Whole-Microbe & Genetic Approach of Vaccine Development

The Way Forward for Vaccine Development and the Challenges Ahead

Download Prospectus

contact form

First Name*

Last Name*

Function*

Job Title*

Company*

Country*

Contact Number*

Email*

How did you hear about us?

Products of Interest
Blood Plasma ProductsAntibody TherapeuticsProtein TherapeuticsViral VaccinesCell TherapyGene TherapyImmunotherapeuticsMedical DeviceOther BiologicsNon-Biologics

Past #VWS Sponsors and Supporters

Silver Sponsor

Advertiser

Pfanstiehl is the market leader of high purity / low endotoxin-low metal excipients for biologics, biosimilars, vaccines, cell culture media and injectable (liquid and lyophilized) formulations and supplies its products to nearly all of the leading global biopharmaceutical companies. Pfanstiehl was founded in 1919 and currently celebrating its 102nd anniversary year in 2021. Pfanstiehl is headquartered at Waukegan, IL, USA and has global presence with sales offices in Switzerland for EMEA & in Singapore for APAC.

Pfanstiehl has manufactured parenteral grade excipients for more than 50 years, and Pfanstiehl’s excipients are critical components in the majority of the top global blockbuster biopharmaceutical drugs & vaccines which have been administered to thousands of patients around the world. Pfanstiehl’s high purity, low endotoxin and low metals Carbohydrates & Amino acids are known as “best in class” due to their high purity, performance, consistency and quality attributes.

For more information, please visit: www.pfanstiehl.com

Exhibitor

USP is an independent non-profit organization that collaborates with the world’s top health and science experts to develop high-quality standards that set the bar for manufacturing and distributing safe and effective medicines, supplements, and food around the globe. Two billion people worldwide have access to quality medicines, dietary supplements, and food as a result of USP’s standards, advocacy and education.

At USP Biologics our primary objective is to keep you at the vanguard of standards that promote the quality of biological medicines. We do this through our rigorous and proven scientific process. And we place the outcome of our process – the physical standard as well as the method or supporting information– into your hands.

We provide a trusted, independent, single source of reliable standards that are available and used globally. Building upon our successes with more traditional biologics including Insulin and Heparin, we engage with thousands of experts, professionals, associations, regulatory agencies, and companies to pave the way for higher standards for the new wave of biologics and biosimilar drugs. It’s logical really: by actively working with the scientific community and making our rigorously researched standards available to the world, we enable you to provide access to quality medicines for all. Through a collaborative process and commitment to quality, our USP’s biologic standards help by delivering key tools and resources to help make critical medicines, such as the insulin family of products, more accessible to the global population.

To assist you in achieving high standards in drug validation and regulatory compliance as well as avoiding potentially costly mistakes, choose our globally renowned scientific approach that has provided trustworthy standards for decades. Logical really. Our process is as robust as the results you will achieve.

So why not talk with us and find out how we can help advance your biologics and biosimilars project with reliable standards?

For more information, please visit: http://www.usp.org/biologics

Supporter

Supporter

Download Prospectus

contact form

First Name*

Last Name*

Function*

Job Title*

Company*

Country*

Contact Number*

Email*

How did you hear about us?

Products of Interest
Blood Plasma ProductsAntibody TherapeuticsProtein TherapeuticsViral VaccinesCell TherapyGene TherapyImmunotherapeuticsMedical DeviceOther BiologicsNon-Biologics